Huagai Capital is an equity investment firm that provides strategic and financial support for start-up stage companies in China.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Huagai Capital is an equity investment firm that provides strategic and financial support for start-up stage companies in China.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2016 | Xiangyi Yanglao | Series A | 1.5M |
2/2019 | Zhiteng Education | Series A | 3.6M |
4/2018 | 13 Month Culture Communication | Series B | 3.2M |
12/2016 | Mahua Fun Age | Post-IPO Equity | 7.2M |
12/2015 | Omescape | Angel Round | 770k |
5/2019 | Zuodashi | Series A | 14.5M |
7/2018 | Ruizhi Hechuang Technology | Seed Round | 0 |
1/2017 | CooTek | Series D | 66M |
6/2018 | Karaku | Series A | - |
5/2022 | Reistone Biopharma | Series A | 0 |
9/2021 | H.Extract | Series C | 0 |
9/2017 | Sino Vision | Series B | 30.6M |
1/2018 | Nine strong | Corporate Round | - |
8/2022 | DeepWay | Series A | 67.2M |
2/2019 | Haihe Biopharma | Series B | 0 |
7/2016 | Gufutv.com | Series A | 3M |
3/2016 | InCarey | Series A | 15.3M |
6/2016 | Founder Radio | Angel Round | 455.1k |
6/2017 | appMagics | Series A | - |
2/2014 | Zizai Tech | Angel Round | 494.1k |
9/2016 | China Automotive Battery Research Institute | Angel Round | 449k |
12/2016 | Tiger Brokers | Series B | 29M |
7/2020 | AccuMedical | Series B | 14.3M |
5/2019 | Life Real | Series A | 1.4M |
5/2018 | Xianlepin | Series A | - |
4/2017 | Haituanjian | Series A | 0 |
5/2022 | Shanghai Perfect Match Flexible Supply Chain Service Co | Series A | - |
12/2017 | No Panda Culture (Bukongwenhua) | Series A | 10.6M |
6/2022 | Kingstar | Venture Round | 15M |
12/2022 | Qitan Technology | Series C | 100.2M |
12/2021 | GenFleet Therapeutics | Series C | 0 |
1/2020 | Alebund Pharmaceuticals | Series A | - |
8/2018 | EdiGene | Series A | 14.5M |
5/2021 | Duality Biologics | Series B | 0 |
7/2021 | PAQ Therapeutics | Series A | 0 |
6/2017 | DDD.ONLINE | Series A | 2.9M |
12/2019 | Kafang Technology | Series A | - |
11/2019 | Genome Wisdom | Series B | 8.5M |
12/2019 | Yijiaoyoupei | Series A | - |
2/2016 | DeZerlin Media | Series A | 1.5M |
5/2016 | Hongkong Gangyingbao | Series A | 1.5M |
1/2015 | Zhaole | Angel Round | 1.5M |
7/2021 | Xianghuanji | Series B | 8.5M |
6/2022 | Huojianpai | Seed Round | - |
8/2016 | Beeplus Co-working Space | Angel Round | - |
3/2020 | Tongcheng Bills Network | Series B | 21.4M |
2/2022 | Clounix | Series A | 0 |
12/2021 | Beijing Sudo Technology | Series A | 0 |
3/2018 | Rebbeca Med | Series A | 2.4M |
5/2014 | LDD Liduoduo | Series A | 1.6M |
7/2017 | Pin Hu Tang | Series A | 1.5M |
2/2018 | Louxiaoyi | Seed Round | 3.2M |
4/2019 | Kexin Health Industry Development | Series D | - |
6/2014 | Octinn | Series A | 10M |
9/2013 | Edustar | Post-IPO Equity | 12.2M |
2/2015 | Greatsoft | Angel Round | 482.1k |
12/2017 | SWS Medical | Post-IPO Equity | 15.6M |
11/2021 | NeuraMatrix | Series A | 0 |
2/2016 | LDD Liduoduo | Post-IPO Equity | 9.2M |
2/2018 | IPao | Angel Round | 477k |
7/2018 | Shukun Technology | Series A | 15M |
5/2019 | OnVideo | Series A | 2.2M |
1/2018 | Cool Academy | Angel Round | - |
5/2020 | Galaxis Automotion | Series D | 14M |
12/2019 | JOINN Biologics | Series A | 60M |
12/2017 | Rogrand | Series C | - |
2/2019 | Shukun Technology | Series B | 29.6M |
11/2015 | COMMCHINA | Post-IPO Equity | 4.7M |
6/2020 | Shukun Technology | Series B | 0 |
5/2015 | Greatsoft | Venture Round | 8.1M |
6/2021 | Qitan Technology | Series B | 62.5M |
7/2018 | Songxiaocai | Series B | 26M |
1/2018 | Yiwai | Series B | 3.1M |
9/2018 | Aidong Super AI | Series A | 1.5M |
9/2020 | Kafang Technology | Series B | - |
4/2021 | EdiGene | Series B | 61.6M |
11/2020 | GensKey | Series C | 0 |
4/2020 | Quantinfo Technology | Series A | 2.8M |
3/2016 | ykyao.com | Series A | 15.4M |
11/2021 | Datong | Private Equity Round | 234.8M |
5/2019 | GeneQuantum Healthcare | Series B | 14.8M |
5/2021 | Reliable Med | Series A | - |
10/2022 | Carmine Therapeutics | Series A | - |
8/2016 | Fe3 Medical | Series B | 3.5M |
8/2020 | MicuRx Pharmaceuticals | Series D | 43.3M |
11/2016 | Zhijia | Angel Round | 443.6k |
12/2021 | MindRank AI | Series A | 19M |
10/2020 | EdiGene | Series B | 0 |
2/2022 | Singlomics | Series B | 0 |
11/2017 | lonwin | Series C | 4.5M |
2/2021 | Shanghai ANE Logistics | Private Equity Round | 300M |
5/2017 | COMMCHINA | Post-IPO Equity | 5.1M |
6/2018 | Kalaku | Series A | 7.8M |
8/2021 | JOINN Biologics | Series B | 150M |
6/2020 | Immvira | Series B | 58M |
2/2016 | ZHONGHE PHARMACEUTICAL | Funding Round | 7.6M |
3/2021 | Synaptic Medical | Series G | 60M |
1/2015 | Biyao | Series A | 1.6M |
6/2022 | Huojianpai | Seed Round | - |
6/2022 | Kingstar | Venture Round | 0 |
5/2022 | Reistone Biopharma | Series A | 0 |
2/2022 | Clounix | Series A | 0 |
2/2022 | Singlomics | Series B | 0 |
12/2021 | GenFleet Therapeutics | Series C | 0 |
12/2021 | MindRank AI | Series A | 0 |
12/2021 | Beijing Sudo Technology | Series A | 0 |
11/2021 | Datong | Private Equity Round | 0 |
11/2021 | NeuraMatrix | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|